Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.6800
-0.009745 (-1.41%)
At close: Jun 9, 2026

RVPH Stock Forecast

OTC-RVPH's stock price has decreased by -95.86% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, RVPH stock has a consensus rating of "Strong Buy" and an average price target of $25. The average 1-year stock price forecast is 3,576.47% higher than the current stock price, while the lowest is $5.00 (+635.29%) and the highest is $40 (+5,782.35%).

Price Target: $25 (+3,576.47%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5.00$25$30$40
Change+635.29%+3576.5%+4311.8%+5782.4%

Analyst Ratings

The average analyst rating for RVPH stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy665442
Buy111100
Hold000110
Sell000000
Strong Sell000000
Total776652

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Alliance Global Partners
Alliance Global Partners
Buy
Reiterates
$30
BuyReiterates$30+4,311.76%May 21, 2026
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aApr 8, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$1.5$1
BuyReiterates$1.5$1+47.06%Apr 1, 2026
D. Boral Capital
D. Boral Capital
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 5, 2026
Chardan Capital
Chardan Capital
Buy
Maintains
$40
BuyMaintains$40+5,782.35%Jan 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.60
from -5.48
EPS Next Year
-1.90
from -1.60
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-10.10M-28.23M-39.50M-30.80M-20.20M-18.56M
Net Income
-8.52M-28.26M-39.26M-29.92M-19.86M-22.53M
EPS
-----5.48-1.60
Free Cash Flow
-6.87M-8.54M-14.01M-21.54M-17.14M-40.70M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-
Avg-1.60
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-